Clinical trial
[rVSVΔG-ZEBOV] Ebola Prevention Vaccine Evaluation in Sierra Leone
NCT02378753 is registered in ClinicalTrials.gov with Centers for Disease Control and Prevention as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- [rVSVΔG-ZEBOV] Ebola Prevention Vaccine Evaluation in Sierra Leone
- Lead sponsor
- Centers for Disease Control and Prevention
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- April 30, 2015
- Completion date
- December 5, 2016
- Enrollment
- 8,651 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.